NRX Pharmaceuticals (NASDAQ:NRXP) stock is surging higher on Thursday thanks to recent results from a clinical trial of its Covid-19 treatment. Source: Shutterstock.com According to the results, 81% of patients taking aviptadil survived to 60 days following infection. For comparison, that percentage was 21% for patients in a control group getting standard care for the…

Bank stocks are on the move Thursday following the release of earnings reports from various companies. Source: Syda Productions / Shutterstock.com We’re diving into those earnings reports below to see what has investors in bank stocks so happy today. Bank Stocks On the Move: Bank of America (BAC) Bank of America (NYSE:BAC) starts us off…

Today, some significant buzz is building around biopharmaceutical company Orphazyme (NASDAQ:ORPH). Indeed, ORPH stock is currently up big today on high volume as investors pile into this play. Currently, investors in Orphazyme have booked paper gains of 36% at the time of writing on today’s outsized move. Source: luchschenF / Shutterstock.com This biopharma play is…

Small biotech companies such as Denmark’s Orphazyme (NASDAQ:ORPH) usually have one major product, which pushes them into the spotlight. For ORPH stock, that one product is Arimoclomol. Source: Iryna Imago / Shutterstock.com Arimoclomol is a drug that could treat the rare progressive genetic disorder called Niemann-Pick Disease Type C (NPC). Investors looking for a breakthrough…

Today, investors in Orphazyme (NASDAQ:ORPH) have seen absolutely massive gains. Shares of OPRH stock peaked as high as $9.35, representing a gain of nearly 57% from yesterday’s close. However, ORPH stock has since given up approximately half of these gains, trading 26% higher at the time of writing. Source: Shutterstock Today’s move comes on the heels of…

In another one of the wild (and arguably unpredictable) adventures of coordinated trading on Reddit, biotechnology firm Orphazyme (NASDAQ:ORPH) recently produced more gyrations on its technical chart than robust seismic activity on the Richter scale. Trading hands as low as $4.75 on an intraday basis this month, ORPH stock reached a blistering $77.77 before closing…

GEO Group (NYSE:GEO) is heading higher on Friday following news that the company’s CEO acquired shares of the stock. Source: JosephRouse / Shutterstock.com According to a recent filing with the U.S. Securities and Exchange Commission (SEC), chairman and CEO George Zoley picked up an additional 166,644 shares of GEO stock. The shares were purchase for…

Orphazyme (NASDAQ:ORPH) is getting off to a rough start on Friday, with ORPH stock down more than 50% in pre-market trading. This comes after the Denmark-based biotech company has rocketed higher in recent weeks. In fact, earlier in June, it saw more than 1,300% gains in a single trading day. So what is the latest…

The meme stock crowd have their sights set on new targets and orphan drug treatment company Orphazyme (NASDAQ:ORPH) is up nearly 90% today as a result. ORPH stock has been trading jaggedly since last week, at one point up more than 1,000% on Friday, June 11. Source: Shutterstock Trading volume of 115 million shares on…

Copyright © 2021 InvestorPlace Media, LLC. All rights reserved. 1125 N. Charles St, Baltimore, MD 21201. Home / Today’s Market / BIIB Stock: 9 Things to Know About Biogen’s Alzheimer Drug Approval Controversy FDA committee members are resigning over the approval By William White, InvestorPlace Writer Jun 11, 2021, 10:24 am EDT June 11, 2021…

THE BARGAIN BIN 3 Cheap Stocks to Buy Even as Markets Hover Near All-Time Highs READ MORE Sponsored by Home / Today’s Market / Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday AMST and ORPH are leading our lists today By William White, InvestorPlace Writer Jun 11, 2021, 7:22 am EDT…

Today, investors in Orphazyme (NASDAQ:ORPH) experienced wild gains. Orphazyme stock closed higher by more than 300%, but at one point, shares were up 1,000%. That is simply spectacular.  Source: Shutterstock This is a stock that halted numerous times today, and has seen a ridiculous number of shares trade hands. By market close, more than 6 million shares…

Today, Orphazyme (NASDAQ:ORPH) is a big mover. And by big mover, I mean ORPH stock is up nearly 1,000% at the time of writing. Source: Shutterstock This is a stock that closed yesterday trading at $5.22. At the time of writing, shares of ORPH stock are trading in excess of $56. Obviously, something is cooking with this…